je.st
news
Tag: genetics
Myriad Genetics Price Target Cut to $31.00
2013-03-05 02:36:49| Biotech - Topix.net
The firm currently has a "buy" rating on the stock. Other equities research analysts have also recently issued reports about the stock.
Tags: price
cut
target
genetics
Hermitage Genetics, Globino Ukraine Conclude Agreement
2013-02-18 01:00:00| ThePigSite - Industry News
UKRAINE - LLC RPE "Globinsky Svinokomplex" established a 1230 sow GGP/GP Hermitage Genetics nucleus in the Ukraine in February of last year.
Tags: agreement
ukraine
conclude
genetics
Seattle Genetics Initiates Two Phase I Trials Of SGN-CD19A
2013-02-06 10:00:00| drugdiscoveryonline News Articles
Seattle Genetics, Inc. recently announced the initiation of two phase I clinical trials of SGN-CD19A, one for patients with B-cell acute lymphoblastic leukemia (ALL) and one for patients with B-cell non-Hodgkin lymphomas
Tags: phase
seattle
trials
genetics
Seattle Genetics Initiates Two Phase I Trials Of SGN-CD19A
2013-02-06 10:00:00| drugdiscoveryonline Home Page
Seattle Genetics, Inc. recently announced the initiation of two phase I clinical trials of SGN-CD19A, one for patients with B-cell acute lymphoblastic leukemia (ALL) and one for patients with B-cell non-Hodgkin lymphomas
Tags: phase
seattle
trials
genetics
Myriad Genetics (MYGN) Announces Quarterly Earnings, Beats Expectations By $0.04 EPS
2013-02-06 02:26:56| Biotech - Topix.net
Myriad Genetics posted its quarterly earnings results on Tuesday. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.04. The company had revenue of $140.70 million for the quarter, compared to the consensus estimate of $143.71 million.
Tags: expectations
quarterly
earnings
announces
Sites : [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] next »